Phase 1 Rivaroxaban Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Excretion of Rivaroxaban in Human Breast Milk

VTE (Venous Thromboembolism)PostpartumBreast Milk Collection+3 more

Thomas Jefferson University10 enrolled1 locationNCT06831474

Recruiting

Phase 1

Phase I Study of MT1011 Injection in Healthy Subjects

Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation

Shaanxi Micot Pharmaceutical Technology Co., Ltd.40 enrolled1 locationNCT07024160